Novartis reports positive results from Novartis five-year VERIFY study in type 2 diabetes
Novartis announced key results from the Phase IV clinical study VERIFY evaluating the long-term efficacy and safety of early combination treatment strategy with metformin plus vildagliptin (dipeptidyl peptidase-4 inhibitor) versus the traditional stepwise approach with metformin. September 18, 2019